machine learning
machine learning

AstraZeneca types up $247M, AI-enabled oncology antibody design pact, joining Absci’s list of pharma allies – FierceBiotech

AstraZeneca types up $247M, AI-enabled oncology antibody design pact, joining Absci’s list of pharma allies  FierceBiotech